These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2619149)
1. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone. Flach AJ; Jaffe NS; Akers WA Ann Ophthalmol; 1989 Nov; 21(11):407-11. PubMed ID: 2619149 [TBL] [Abstract][Full Text] [Related]
2. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Flach AJ; Kraff MC; Sanders DR; Tanenbaum L Arch Ophthalmol; 1988 Apr; 106(4):480-3. PubMed ID: 3355415 [TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Flach AJ; Graham J; Kruger LP; Stegman RC; Tanenbaum L Arch Ophthalmol; 1988 Mar; 106(3):344-7. PubMed ID: 3345153 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Stewart R; Grosserode R; Cheetham JK; Rosenthal A Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737 [TBL] [Abstract][Full Text] [Related]
5. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Flach AJ; Lavelle CJ; Olander KW; Retzlaff JA; Sorenson LW Ophthalmology; 1988 Sep; 95(9):1279-84. PubMed ID: 3062540 [TBL] [Abstract][Full Text] [Related]
6. Ketorolac tromethamine in the maintenance of intraoperative mydriasis. Gupta VP; Dhaliwal U; Prasad N Ophthalmic Surg Lasers; 1997 Sep; 28(9):731-8. PubMed ID: 9304635 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191 [TBL] [Abstract][Full Text] [Related]
8. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. Flach AJ; Dolan BJ Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013 [TBL] [Abstract][Full Text] [Related]
9. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. Simone JN; Pendelton RA; Jenkins JE J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648 [TBL] [Abstract][Full Text] [Related]
12. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. Sandoval HP; De Castro LE; Vroman DT; Solomon KD J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866 [TBL] [Abstract][Full Text] [Related]
14. Phase II results of an intraocular steroid delivery system for cataract surgery. Chang DF; Garcia IH; Hunkeler JD; Minas T Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery. Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738 [TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Tan DT; Chee SP; Lim L; Lim AS Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469 [TBL] [Abstract][Full Text] [Related]
17. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing. Bucci FA; Waterbury LD Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702 [TBL] [Abstract][Full Text] [Related]
18. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Rabiah PK; Fiscella RG; Tessler HH Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961 [TBL] [Abstract][Full Text] [Related]
19. Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug: ability to inhibit post-radical pelvic surgery adhesions in a porcine model. Montz FJ; Monk BJ; Lacy SM; Fowler JM Gynecol Oncol; 1993 Jan; 48(1):76-9. PubMed ID: 8423025 [TBL] [Abstract][Full Text] [Related]
20. Comparison of ketorolac and meperidine in patients with postoperative pain--impact on health care utilization. Stahlgren LR; Trierweiler M; Tommeraasen M; Mehlisch D; Otterson W; Maneatis T; Bynum L; DiGiorgio E Clin Ther; 1993; 15(3):571-80; discussion 570. PubMed ID: 8364949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]